Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.

Garcia-Borreguero D, Benitez A, Kohnen R, Allen R.

Postgrad Med. 2015 Jun 16:1-10. [Epub ahead of print]

PMID:
26077324
2.

Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations.

Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Stebbins GT, Schrag A; MDS Committee on Rating Scales.

J Clin Sleep Med. 2014 Dec 15;10(12):1351-7. doi: 10.5664/jcsm.4300.

3.

Review of diagnostic instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations.

Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Stebbins GT, Schrag A; MDS Committee on Rating Scales.

J Clin Sleep Med. 2014 Dec 15;10(12):1343-9. doi: 10.5664/jcsm.4298.

4.

Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).

Earley CJ, Connor J, Garcia-Borreguero D, Jenner P, Winkelman J, Zee PC, Allen R.

Sleep Med. 2014 Nov;15(11):1288-301. doi: 10.1016/j.sleep.2014.05.009. Epub 2014 Jun 16. Review.

PMID:
25201131
5.

Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.

Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB; International Restless Legs Syndrome Study Group.

Sleep Med. 2014 Aug;15(8):860-73. doi: 10.1016/j.sleep.2014.03.025. Epub 2014 May 17.

PMID:
25023924
6.

An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment.

Garcia-Borreguero D, Williams AM.

Curr Opin Neurol. 2014 Aug;27(4):493-501. doi: 10.1097/WCO.0000000000000117. Review.

PMID:
24978636
7.

Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.

Garcia-Borreguero D, Patrick J, DuBrava S, Becker PM, Lankford A, Chen C, Miceli J, Knapp L, Allen RP.

Sleep. 2014 Apr 1;37(4):635-43. doi: 10.5665/sleep.3558.

8.

Comparison of pregabalin with pramipexole for restless legs syndrome.

Allen RP, Chen C, Garcia-Borreguero D, Polo O, DuBrava S, Miceli J, Knapp L, Winkelman JW.

N Engl J Med. 2014 Feb 13;370(7):621-31. doi: 10.1056/NEJMoa1303646.

9.

Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.

Trenkwalder C, Beneš H, Grote L, García-Borreguero D, Högl B, Hopp M, Bosse B, Oksche A, Reimer K, Winkelmann J, Allen RP, Kohnen R; RELOXYN Study Group.

Lancet Neurol. 2013 Dec;12(12):1141-50. doi: 10.1016/S1474-4422(13)70239-4. Epub 2013 Oct 18. Erratum in: Lancet Neurol. 2013 Dec;12(12):1133.

PMID:
24140442
10.

A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions.

Roth T, Arnold LM, Garcia-Borreguero D, Resnick M, Clair AG.

Sleep Med Rev. 2014 Jun;18(3):261-71. doi: 10.1016/j.smrv.2013.07.005. Epub 2013 Oct 9. Review.

PMID:
24119681
11.

Catalogue of knowledge and skills for sleep medicine.

Penzel T, Pevernagie D, Dogas Z, Grote L, de Lacy S, Rodenbeck A, Bassetti C, Berg S, Cirignotta F, d'Ortho MP, Garcia-Borreguero D, Levy P, Nobili L, Paiva T, Peigneux P, Pollmächer T, Riemann D, Skene DJ, Zucconi M, Espie C; Sleep Medicine Committee; European Sleep Research Society.

J Sleep Res. 2014 Apr;23(2):222-38. doi: 10.1111/jsr.12095. Epub 2013 Oct 7.

12.

Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.

Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG; Medical Advisory Board of the Willis-Ekbom Disease Foundation.

Mayo Clin Proc. 2013 Sep;88(9):977-86. doi: 10.1016/j.mayocp.2013.06.016.

PMID:
24001490
13.

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.

Garcia-Borreguero D, Kohnen R, Silber MH, Winkelman JW, Earley CJ, Högl B, Manconi M, Montplaisir J, Inoue Y, Allen RP.

Sleep Med. 2013 Jul;14(7):675-84. doi: 10.1016/j.sleep.2013.05.016.

14.

Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease).

Garcia-Borreguero D, Kohnen R, Boothby L, Tzonova D, Larrosa O, Dunkl E.

Sleep. 2013 Jul 1;36(7):1101-1109.

15.

Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 - 3 mg/24 h for up to 5 years.

Dohin E, Högl B, Ferini-Strambi L, Schollmayer E, Fichtner A, Bauer L, García-Borreguero D.

Expert Opin Pharmacother. 2013 Jan;14(1):15-25. doi: 10.1517/14656566.2013.758251. Epub 2012 Dec 21.

PMID:
23256574
16.

Efficacy, safety and risk of augmentation of rotigotine for treating restless legs syndrome.

Inoue Y, Hirata K, Hayashida K, Hattori N, Tomida T, Garcia-Borreguero D; Rotigotine Study Group.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:326-33. doi: 10.1016/j.pnpbp.2012.10.012. Epub 2012 Oct 25.

PMID:
23103551
17.

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society.

Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, O'Keeffe S, Trenkwalder C, Högl B, Benes H, Jennum P, Partinen M, Fer D, Montagna P, Bassetti CL, Iranzo A, Sonka K, Williams AM; European Federation of Neurological Societies; European Neurological Society; European Sleep Research Society.

Eur J Neurol. 2012 Nov;19(11):1385-96. doi: 10.1111/j.1468-1331.2012.03853.x. Epub 2012 Sep 3.

PMID:
22937989
18.

From restless legs syndrome to Willis-Ekbom disease: a condition reaches full age.

García-Borreguero D.

Sleep Med Rev. 2012 Aug;16(4):281-2. doi: 10.1016/j.smrv.2012.03.004. Epub 2012 Apr 22. No abstract available.

PMID:
22531480
19.

Augmentation in the treatment of restless legs syndrome with transdermal rotigotine.

Beneš H, García-Borreguero D, Ferini-Strambi L, Schollmayer E, Fichtner A, Kohnen R.

Sleep Med. 2012 Jun;13(6):589-97. doi: 10.1016/j.sleep.2011.09.016. Epub 2012 Apr 13.

PMID:
22503658
20.

Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks.

García-Borreguero D, Högl B, Ferini-Strambi L, Winkelman J, Hill-Zabala C, Asgharian A, Allen R.

Mov Disord. 2012 Feb;27(2):277-83. doi: 10.1002/mds.24889. Epub 2012 Jan 4.

PMID:
22328464
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk